HUNTINGTON NATIONAL BANK - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,152
+9681.8%
79
+7800.0%
0.00%
Q2 2023$220.0%10.0%0.00%
Q1 2023$22
+10.0%
10.0%0.00%
Q4 2022$2010.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$0
-100.0%
1
-99.8%
0.00%
Q1 2020$6,000
-78.6%
529
-74.5%
0.00%
Q4 2018$28,000
-9.7%
2,071
-6.2%
0.00%
Q3 2018$31,000
-16.2%
2,207
-7.3%
0.00%
-100.0%
Q2 2018$37,000
+15.6%
2,381
+21.3%
0.00%0.0%
Q1 2018$32,0001,9630.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders